Cardiovascular Drugs Practice Questions

Q: Which of the following drugs causes vasodilation primarily through direct effects on vascular smooth muscle?

Hydralazine. ***Hydralazine*** - **Hydralazine** is a direct-acting **vasodilator** that primarily relaxes **arteriolar smooth muscle**, leading to decreased peripheral resistance and afterload. - Its exact mechanism of action is not fully understood, but it is thought to involve inhibition of **IP3-induced calcium release** from the sarcoplasmic reticulum. *Aminophylline* - **Aminophylline** is a methylxanthine derivative structurally similar to **theophylline**, primarily used as a bronchodilator. - Its vasodilatory effects are secondary to inhibition of **phosphodiesterase**, which increases cyclic adenosine monophosphate (cAMP) levels. *Amrinone* - **Amrinone** is a **phosphodiesterase-3 inhibitor** (PDE-3 inhibitor) that increases intracellular **cAMP** in cardiac myocytes and vascular smooth muscle cells. - This leads to both **positive inotropy** in the heart and **vasodilation** in blood vessels, but its primary action is not direct smooth muscle relaxation. *Sildenafil* - **Sildenafil** is a **phosphodiesterase-5 inhibitor** (PDE-5 inhibitor) primarily used for erectile dysfunction and pulmonary hypertension. - It works by preventing the degradation of **cGMP**, leading to relaxation of smooth muscle in specific vascular beds, not a general direct relaxation of all vascular smooth muscle typically associated with drugs like hydralazine.

Q: Which of the following beta blockers is not considered cardioselective?

Carvedilol. ***Carvedilol*** - **Carvedilol** is a **non-selective beta-blocker** and also possesses **alpha-1 adrenergic blocking activity**, differentiating it from cardioselective agents. - Its mechanism of action involves blocking both **beta-1** and **beta-2 receptors**, as well as **alpha-1 receptors**, which contributes to its broader therapeutic uses, such as in heart failure. *Metoprolol* - **Metoprolol** is considered a **cardioselective (beta-1 selective) beta-blocker** at lower doses, primarily affecting the heart. - It has a lower propensity to cause **bronchoconstriction** or affect peripheral circulation compared to non-selective agents. *Atenolol* - **Atenolol** is a **cardioselective beta-blocker** that preferentially blocks **beta-1 adrenergic receptors** in the heart. - It is frequently used for conditions where specific **cardiac effects** are desired while minimizing impact on other systems. *Esmolol* - **Esmolol** is an **ultra-short-acting**, **cardioselective beta-blocker** that primarily blocks **beta-1 receptors**. - Its rapid onset and short duration of action make it particularly useful in **acute care settings**, such as perioperative hypertension or supraventricular tachyarrhythmias.

Q: Hypertension is associated with all of the following medications except:

Levodopa. ***Levodopa*** - **Levodopa** is a precursor to dopamine used in Parkinson's disease and is not directly associated with inducing or exacerbating hypertension. - While it can cause some cardiovascular side effects like **orthostatic hypotension**, it generally does not raise blood pressure. *Erythropoietin* - **Erythropoietin** can cause hypertension by increasing blood viscosity through elevated red blood cell mass and activating endothelin-1 leading to **vasoconstriction**. - It specifically increases the risk of **hypertensive crises** and can worsen pre-existing hypertension. *Cyclosporine* - **Cyclosporine** is an immunosuppressant that causes hypertension by inducing renal vasoconstriction, increasing sympathetic tone, and altering endothelial function. - It leads to **sodium and water retention** and directly impacts vascular resistance. *NSAID* - **Nonsteroidal anti-inflammatory drugs (NSAIDs)** can elevate blood pressure by inhibiting prostaglandin synthesis, which otherwise mediates vasodilation and natriuresis. - This inhibition can lead to **sodium and water retention** and increased systemic vascular resistance.

Q: For a patient on quinidine, select the most likely side effect to occur.

prolonged QT interval. ***prolonged QT interval*** - Quinidine is a **Class IA antiarrhythmic drug** that blocks sodium and potassium channels, leading to a significant **prolongation of the QT interval** on an electrocardiogram [1]. - This prolongation can increase the risk of **Torsades de Pointes**, a life-threatening polymorphic ventricular tachycardia [1]. *peripheral neuropathy* - **Peripheral neuropathy** is not a common or characteristic side effect associated with quinidine therapy. - Neuropathies are typically linked to drugs like **isoniazid** or certain **chemotherapeutic agents**. *bradycardia* - While quinidine can affect cardiac conduction, it's more commonly associated with **tachycardia** (due to anticholinergic effects) or arrhythmias rather than significant bradycardia [2]. - **Beta-blockers** and **calcium channel blockers** are more likely to cause symptomatic bradycardia. *action tremor* - **Action tremor** is generally not a recognized side effect of quinidine. - Tremors are often associated with other medications such as **lithium**, **valproic acid**, or **beta-agonists**.

Q: Nitrates can be used for all of the following conditions except:

Cyanide poisoning. ***Cyanide poisoning*** - This is the correct answer because **organic nitrates** (nitroglycerin, isosorbide dinitrate) used in cardiovascular practice are **not indicated** for cyanide poisoning. - While **nitrites** (amyl nitrite, sodium nitrite) - different compounds - can induce methemoglobinemia to bind cyanide, these are not the same as the organic nitrates used for cardiovascular conditions. - Current primary treatment for cyanide poisoning uses **hydroxocobalamin** and **sodium thiosulfate**, not cardiovascular nitrate preparations. *Congestive heart failure* - Nitrates cause **venodilation**, which reduces **preload** on the heart, thereby decreasing myocardial wall stress and oxygen demand. - This effect is beneficial in **acute decompensated heart failure** to manage symptoms like pulmonary congestion and dyspnea. - Commonly used preparations include IV nitroglycerin and sublingual nitroglycerin for acute management. *Esophageal spasm* - Nitrates relax **smooth muscle**, including the smooth muscle of the esophagus. - This property makes them useful in relieving the pain and discomfort associated with **diffuse esophageal spasm**. - Sublingual nitroglycerin can provide symptomatic relief. *Renal colic* - Nitrates cause **smooth muscle relaxation**, which can help to dilate the **ureters**. - This dilation can facilitate the passage of kidney stones and alleviate the severe pain associated with **renal colic**. - Though NSAIDs are first-line, nitrates may be used adjunctively for smooth muscle relaxation.

Q: All the following antihypertensive drugs are used in pregnancy except for one. Which one is contraindicated?

Enalapril. ***Enalapril*** - **ACE inhibitors** like enalapril are absolutely contraindicated in pregnancy due to their association with **fetal renal dysfunction**, oligohydramnios, and **fetal death**. - They should be avoided throughout all trimesters, especially during the **second and third trimesters**. *Nifedipine* - **Nifedipine**, a calcium channel blocker, is considered a safe and effective antihypertensive agent during pregnancy. - It rapidly reduces blood pressure and is often used for acute management of **severe hypertension** in pregnancy, including pre-eclampsia. *Labetalol* - **Labetalol** is a combined alpha and beta-blocker that is a first-line treatment for hypertension in pregnancy. - It has a good safety profile for both the mother and the fetus, with extensive clinical experience supporting its use. *Methyldopa* - **Methyldopa** is one of the oldest and most studied antihypertensive drugs in pregnancy and is generally considered a first-line agent. - It acts centrally as an alpha-2 adrenergic agonist, reducing sympathetic outflow, and has shown good safety outcomes for long-term use.

Q: Which antihypertensive agent is used topically to treat alopecia and should be used with caution in young females?

Minoxidil. ***Minoxidil*** - **Minoxidil** is a direct **vasodilator** that, when applied topically, stimulates hair growth and is commonly used for **androgenetic alopecia**. - It should be used with caution in young females due to the potential for **hypertrichosis** (unwanted hair growth) outside the scalp if not applied precisely. *Hydralazine* - **Hydralazine** is a direct-acting **vasodilator** primarily used orally or intravenously to treat moderate to severe hypertension and heart failure. - It is not used topically for alopecia and acts differently on blood vessels than minoxidil. *Prazosin* - **Prazosin** is an **alpha-1 adrenergic blocker** used orally to treat hypertension, benign prostatic hyperplasia, and sometimes PTSD. - It is not indicated for topical use in alopecia. *Indapamide* - **Indapamide** is a **thiazide-like diuretic** that acts by increasing the excretion of sodium and water, primarily used to treat hypertension and edema. - It has no known role in the topical treatment of alopecia.

Q: What is the role of Bosentan in the treatment of pulmonary arterial hypertension?

Endothelin receptor blocker. ***Endothelin receptor blocker***- Bosentan is an **endothelin receptor antagonist** that blocks the effects of endothelin-1, a potent vasoconstrictor and smooth muscle proliferator [1, 3].- By blocking **endothelin receptors**, Bosentan causes vasodilation and reduces pulmonary vascular remodeling in patients with pulmonary arterial hypertension (PAH) [1, 2, 3].*ACEI*- **Angiotensin-converting enzyme inhibitors (ACEIs)** primarily act on the **renin-angiotensin-aldosterone system** to lower blood pressure in systemic hypertension and heart failure.- They are **not indicated for the treatment of pulmonary arterial hypertension** as their mechanism of action does not directly target the primary pathophysiology of PAH.*IIb/IIIa receptor blocker*- **Glycoprotein IIb/IIIa receptor blockers** are potent antiplatelet agents used in acute coronary syndromes and percutaneous coronary interventions to prevent **thrombosis**.- These agents specifically interfere with platelet aggregation and have **no role in the management of pulmonary arterial hypertension**.*Calcium channel blocker*- **Calcium channel blockers (CCBs)** are used in a small subset of PAH patients who demonstrate vasoreactivity on acute testing.- However, Bosentan is **not a calcium channel blocker**; it works through endothelin receptor antagonism, which is a completely different mechanism of action.

Q: A mixed α1 blocker and 5-HT1A receptor agonist, used as an antihypertensive agent, is which of the following?

Urapidil. ***Urapidil*** - **Urapidil** acts as a **mixed α1-blocker** and has an additional effect as a **5-HT1A receptor agonist**, which contributes to its antihypertensive properties beyond direct vasodilation. - Its unique dual mechanism sets it apart from other alpha-blockers by also modulating serotonin pathways to reduce blood pressure. *Trimazosin* - **Trimazosin** is a **direct-acting peripheral vasodilator** primarily described as an **alpha-adrenergic blocker**, but it does not possess significant 5-HT1A receptor agonist activity. - It is an older antihypertensive medication not commonly used today, with a primary mechanism focused solely on alpha-blocking. *Tamsulosin* - **Tamsulosin** is a **selective α1A-adrenergic receptor antagonist**, specifically used to treat **benign prostatic hyperplasia (BPH)** symptoms by relaxing smooth muscle in the prostate and bladder neck. - It does not have significant 5-HT1A receptor agonist activity, and its primary use is not for general hypertension management. *Doxazosin* - **Doxazosin** is a **selective α1-adrenergic receptor antagonist** used to treat both **hypertension** and **benign prostatic hyperplasia (BPH)**. - While it effectively blocks alpha-1 receptors to lower blood pressure, it does not exert significant agonistic effects on 5-HT1A receptors.

Question 1

Which of the following drugs causes vasodilation primarily through direct effects on vascular smooth muscle?

Accepted Answer

Hydralazine

Answer

Aminophylline

Answer

Amrinone

Answer

Sildenafil

Question 2

Which of the following beta blockers is not considered cardioselective?

Accepted Answer

Carvedilol

Answer

Atenolol

Answer

Esmolol

Answer

Metoprolol

Question 3

Hypertension is associated with all of the following medications except:

Accepted Answer

Levodopa

Answer

Cyclosporine

Answer

NSAID

Answer

Erythropoietin

Question 4

For a patient on quinidine, select the most likely side effect to occur.

Accepted Answer

prolonged QT interval

Answer

peripheral neuropathy

Answer

bradycardia

Answer

action tremor

Question 5

Nitrates can be used for all of the following conditions except:

Accepted Answer

Cyanide poisoning

Answer

Esophageal spasm

Answer

Congestive heart failure

Answer

Renal colic

Question 6

All the following antihypertensive drugs are used in pregnancy except for one. Which one is contraindicated?

Accepted Answer

Enalapril

Answer

Nifedipine

Answer

Labetalol

Answer

Methyldopa

Question 7

The choice of antihypertensive medication also depends upon the co-morbid illness of the patient, and all of the following recommendations have been made except:

Accepted Answer

In hypertensive patients with gout, diuretics are the first-line treatment.

Answer

In hypertensive patients with heart failure, ACE inhibitors may be preferred

Answer

In hypertensive patients with migraine, beta blockers are an excellent choice

Answer

In hypertensive patients with peripheral vascular disease, calcium channel blockers are recommended

Question 8

Which antihypertensive agent is used topically to treat alopecia and should be used with caution in young females?

Accepted Answer

Minoxidil

Answer

Hydralazine

Answer

Prazosin

Answer

Indapamide

Question 9

What is the role of Bosentan in the treatment of pulmonary arterial hypertension?

Accepted Answer

Endothelin receptor blocker

Answer

ACEI

Answer

IIb/IIIa receptor blocker

Answer

Calcium channel blocker

Question 10

A mixed α1 blocker and 5-HT1A receptor agonist, used as an antihypertensive agent, is which of the following?

Accepted Answer

Urapidil

Answer

Trimazosin

Answer

Tamsulosin

Answer

Doxazosin

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?